- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Glenmark stock downgraded to Sell by ICICI Securities despite price target hike | 6 | Investing.com | ||
| Fr | ICICI Securities stuft Glenmark-Aktie trotz Kurszielerhöhung auf 'Verkaufen' herab | 3 | Investing.com Deutsch | ||
| 16.07. | Glenmark Pharmaceuticals Ltd up for five straight sessions | 2 | capitalmarket.com | ||
| 14.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 14.07. | Glenmark Pharma receives warning letter from USFDA for Indore facility | 2 | capitalmarket.com | ||
| 13.07. | Breakout Stocks: How to trade Glenmark Pharma, Jaiprakash Power Ventures & EID Parry that hit fresh 52-week high? | 3 | Times of India | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 11.07. | Glenmark Pharma among 8 stocks that hit 52-week highs, rally up to 35% in a month | 2 | Times of India | ||
| 11.07. | Gainers & Losers: Glenmark Pharma, BSE among 7 stocks that hogged the limelight today | 2 | Times of India | ||
| 11.07. | Glenmark Pharma hits record high after $2B licensing deal for cancer drug | 2 | iNVEZZ.com | ||
| 11.07. | Shares Of Glenmark Pharmaceuticals Jump 10% After Deal With AbbVie; USD 2 Billion To Commercialise Cancer & Autoimmune Diseases Healing Drug | 4 | The Free Press Journal | ||
| 11.07. | Mid-day Trade: Sensex falls 648 points, Nifty below 25,200 as TCS drags IT; Glenmark hits 10% upper circuit | 2 | ZEE Business | ||
| 11.07. | Glenmark Pharmaceuticals Ltd leads gainers in 'A' group | 2 | capitalmarket.com | ||
| 11.07. | Glenmark Pharma soars on AbbVie licensing deal for cancer therapy ISB 2001 | 3 | capitalmarket.com | ||
| 11.07. | Glenmark shares spike to 52-week high after $1.93 billion oncology deal with AbbVie - what should investors watch next? | 4 | ZEE Business | ||
| 11.07. | Glenmark Pharmaceuticals: HSBC erhöht Kursziel auf 2.275 INR | 3 | Investing.com Deutsch | ||
| 11.07. | Glenmark Pharmaceuticals price target raised to INR2,275 by HSBC | 3 | Investing.com | ||
| 11.07. | Glenmark strikes $700 million deal with AbbVie for blood cancer drug ISB 2001 | 6 | ZEE Business | ||
| 11.07. | India's Glenmark Pharma shares hit record high on AbbVie cancer drug deal | 2 | Investing.com | ||
| 11.07. | Stock Alert: TCS, Tata Elxsi, IREDA, Anand Rathi, Glenmark Pharma | 5 | capitalmarket.com | ||
| 10.07. | Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody | 321 | PR Newswire | ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM)NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 /PRNewswire/ -- IGI Therapeutics... ► Artikel lesen |
1 2 3 4 5 Weiter >>
93 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,115 | +1,58 % | Minimaler Kursabschlag bei der Sinopharm Group-Aktie (2,033 €) | Die Wertschätzung für den Anteilsschein der Sinopharm Group hat sich am Aktienmarkt heute kaum geändert. Zuletzt zahlten Investoren für das Papier 2,03 Euro. Jahreschart der Sinopharm Group Ltd-Aktie... ► Artikel lesen | |
| CSPC PHARMA | 0,943 | +1,24 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURNS | ||
| WUXI BIOLOGICS | 3,230 | +3,66 % | Kursverluste für den Anteilsschein von WuXi Biologics (3,009 €) | An der Börse liegt das Wertpapier von WuXi Biologics gegenwärtig im Minus. Das Papier notiert aktuell bei 3,01 Euro. An der Börse liegt der Anteilsschein von WuXi Biologics zur Stunde im Minus. Die... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,956 | 0,00 % | Dividendenbekanntmachungen (24.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APTARGROUP INC US0383361039 0,45 USD 0,3823 EUR BLOOMSBURY PUBLISHING PLC GB0033147751 0,1154 GBP 0,1331 EUR CALNEX SOLUTIONS PLC GB00BMBK7016 0... ► Artikel lesen | |
| GEDEON RICHTER | 25,440 | +0,08 % | Gedeon Richter Plc.: Transactions with Treasury Shares | ||
| DR REDDYS | 12,200 | +0,83 % | Dr Reddys Lab gains after Q1 PAT jumps 2% YoY to Rs 1,418 cr | ||
| ASPEN PHARMACARE | 5,650 | +0,89 % | ASPEN PHARMACARE HOLDINGS LIMITED - Notice regarding the release of Aspens financial results for the year ending 30 June 2025, and results presentation | ||
| SHANGHAI PHARMACEUTICALS | 1,400 | +0,72 % | Dividendenbekanntmachungen (16.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACERINOX SA ES0132105018 - 0,31 EUR ALAMO GROUP INC US0113111076 0,3 USD 0,2586 EUR APOGEE ENTERPRISES INC US0375981091 0,26 USD 0... ► Artikel lesen | |
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,149 | +2,05 % | HSI Closes at 24,203, Up 63 pts; HSTI Closes at 5,283, Up 35 pts; CHINA SHENHUA Up over 5%; SINO BIOPHARM, WH GROUP, SIHUAN PHARM, 3SBIO, CH ENERGY ENG Hit New Highs; Market Turnover Rises | ||
| LUYE PHARMA | 0,410 | +0,49 % | LUYE PHARMA (02186): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025 | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,615 | +2,50 % | CHINARES PHARMA Plans to Establish Joint Venture Innovation Investment Fund | ||
| HANSOH PHARMACEUTICAL | 3,760 | -0,53 % | HSI Up 326 pts; HSTI Up 89 pts; ZTO EXPRESS-W Up over 6%; HANSOH PHARMA, NONGFU SPRING, CHINAHONGQIAO, J&T EXPRESS-W, WH GROUP Hit New Highs; Market Turnover Rises | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,870 | 0,00 % | Dividendenbekanntmachungen (30.04.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AG MORTGAGE INVESTMENT TRUST INC US0012285013 0,2 USD EUR ALLIED PROPERTIES REAL ESTATE INVESTMENT ... CA0194561027 0,15 CAD 0... ► Artikel lesen | |
| KALBE FARMA | 0,072 | 0,00 % | KLBF subsidiary partners with GE HealthCare to produce local CT scans: KLBF inaugurates new factory ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.